NorthRock Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.12M | Buy |
34,262
+14,986
| +78% | +$1.73M | 0.07% | 136 |
|
|
2025
Q4 | $1.99M | Sell |
19,276
-25,783
| -57% | -$2.42M | 0.03% | 190 |
|
|
2025
Q3 | $3.78M | Buy |
45,059
+5,731
| +15% | +$472K | 0.07% | 132 |
|
|
2025
Q2 | $3.14M | Buy |
39,328
+6,614
| +20% | +$526K | 0.08% | 97 |
|
|
2025
Q1 | $2.96M | Sell |
32,714
-3,545
| -10% | -$331K | 0.1% | 89 |
|
|
2024
Q4 | $3.63M | Sell |
36,259
-3,288
| -8% | -$339K | 0.12% | 81 |
|
|
2024
Q3 | $4.52M | Sell |
39,547
-4,079
| -9% | -$485K | 0.15% | 75 |
|
|
2024
Q2 | $5.43M | Buy |
43,626
+286
| +0.7% | +$36.8K | 0.2% | 61 |
|
|
2024
Q1 | $5.75M | Buy |
43,340
+6,554
| +18% | +$808K | 0.22% | 62 |
|
|
2023
Q4 | $4.04M | Buy |
36,786
+10,708
| +41% | +$1.11M | 0.17% | 75 |
|
|
2023
Q3 | $2.68M | Buy |
26,078
+4,748
| +22% | +$512K | 0.28% | 41 |
|
|
2023
Q2 | $2.46M | Buy |
21,330
+1,098
| +5% | +$125K | 0.27% | 39 |
|
|
2023
Q1 | $2.15M | Sell |
20,232
-453
| -2% | -$48.9K | 0.23% | 43 |
|
|
2022
Q4 | $2.3M | Sell |
20,685
-347
| -2% | -$35.5K | 0.26% | 41 |
|
|
2022
Q3 | $1.81M | Buy |
21,032
+719
| +4% | +$64.2K | 0.21% | 50 |
|
|
2022
Q2 | $1.85M | Buy |
20,313
+575
| +3% | +$51K | 0.19% | 54 |
|
|
2022
Q1 | $1.62M | Buy |
19,738
+1,718
| +10% | +$135K | 0.15% | 71 |
|
|
2021
Q4 | $1.38M | Sell |
18,020
-7,646
| -30% | -$609K | 0.1% | 78 |
|
|
2021
Q3 | $1.93M | Buy |
25,666
+2,276
| +10% | +$173K | 0.16% | 56 |
|
|
2021
Q2 | $1.82M | Sell |
23,390
-302
| -1% | -$22.5K | 0.15% | 52 |
|
|
2021
Q1 | $1.74M | Buy |
23,692
+6,742
| +40% | +$497K | 0.16% | 56 |
|
|
2020
Q4 | $1.32M | Sell |
16,950
-354
| -2% | -$27.1K | 0.13% | 66 |
|
|
2020
Q3 | $1.37M | Buy |
17,304
+8,279
| +92% | +$648K | 0.15% | 61 |
|
|
2020
Q2 | $666K | Buy |
9,025
+2,178
| +32% | +$164K | 0.08% | 101 |
|
|
2020
Q1 | $503K | Sell |
6,847
-2,475
| -27% | -$195K | 0.07% | 109 |
|
|
2019
Q4 | $809K | Buy |
9,322
+1,455
| +18% | +$120K | 0.09% | 114 |
|
|
2019
Q3 | $636K | Buy |
7,867
+4,122
| +110% | +$330K | 0.09% | 107 |
|
|
2019
Q2 | $301K | Buy |
3,745
+69
| +2% | +$5.28K | 0.09% | 56 |
|
|
2019
Q1 | $293K | Sell |
3,676
-57
| -2% | -$4.26K | 0.08% | 61 |
|
|
2018
Q4 | $277K | Buy |
3,733
+368
| +11% | +$26K | 0.08% | 67 |
|
|
2018
Q3 | $230K | Buy |
+3,365
| New | +$214K | 0.07% | 59 |
|
|
2017
Q1 | – | Sell |
-3,993
| Closed | -$225K | – | 54 |
|
|
2016
Q4 | $225K | Buy |
3,993
+141
| +4% | +$8.25K | 0.08% | 48 |
|
|
2016
Q3 | $231K | Buy |
+3,852
| New | +$225K | 0.1% | 40 |
|
|
2016
Q2 | – | Sell |
-4,047
| Closed | -$206K | – | 51 |
|
|
2016
Q1 | $206K | Buy |
4,047
+47
| +1% | +$2.3K | 0.11% | 43 |
|
|
2015
Q4 | $204K | Buy |
+4,000
| New | +$202K | 0.12% | 33 |
|
|
2015
Q3 | – | Sell |
-3,990
| Closed | -$218K | – | 53 |
|
|
2015
Q2 | $218K | Buy |
+3,990
| New | +$224K | 0.1% | 42 |
|
Other funds holding MRK
VCM
VPM
NorthRock Partners's MRK Position: Q1 2026 in Review
NorthRock Partners increased its Merck (MRK) stake by 78% in Q1 2026, buying an estimated $1.73M and bringing the position to 34,262 shares worth $4.12M. The position accounts for 0.07% of the portfolio, ranked #136.
NorthRock Partners first reported a position in MRK in Q2 2015 and has held it in 36 quarters since. The position peaked at $5.75M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- NorthRock Partners held 34,262 shares of Merck worth $4.12M as of Q1 2026.
- NorthRock Partners bought 14,986 Merck shares in Q1 2026, an estimated $1.73M.
- Merck made up 0.07% of NorthRock Partners's portfolio in Q1 2026, its #136 holding.
- NorthRock Partners first reported a position in Merck in Q2 2015 and has held it in 36 quarters since.
- NorthRock Partners's Merck position peaked at $5.75M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on NorthRock Partners's 13F filing for Q1 2026, filed 15 May 2026.